Michel Vanbrabant, iSTAR Medical - Delivering Breakthrough Eye Care Solutions | LSI Europe '24

MINIject® is iSTAR Medical’s most advanced product, and is approved in Europe for the treatment of Glaucoma – the leading cause of irreversible blindness. Minimally-Invasive Glaucoma Surgery (MIGS) devices are considered the future in glaucoma treatment.
Speakers
Michel Vanbrabant
Michel Vanbrabant
CEO, iSTAR Medical